First OTC birth control pill approved; HHS leader tells vaccine makers to set 'reasonable' prices for Covid shots

The FDA approval could transform the way contraception is delivered in the United States.

July 13, 2023 Check out STAT+

Sponsored By

Perrigo via AP FDA approves first over-the-counter birth control pill The FDA has approved the first over-the-counter birth control pill, a medicine called Opill made by Perrigo. By Ed Silverman STAT+ | HHS leader to vaccine makers: Set 'reasonable' prices for your next round of Covid-19 vaccines Becerra's letter about Covid-19 vaccines comes after Pfizer and Moderna were accused of price gouging for their shots. By Ed Silverman STAT+ | How a key Senate committee is planning to regulate pharmacy benefit managers A key Senate health care panel has developed a plan to tackle reforms to middlemen known as pharmacy benefit managers. By Rachel Cohrs Adobe Why more Americans aren't using the 988 mental-health crisis hotline A new survey suggests some people may be hesitant to call 988 because they're concerned about getting the police involved. By Annalisa Merelli STAT+ | More hospitals are billing patients as online messages surge Hospitals including Cleveland Clinic and University of Washington have new billing policies for responding to patient portal messages. By Mohana Ravindranath Doctors use precision medicine to show melanoma drugs can shrink rare brain tumor by 90% Melanoma drugs shrank a rare brain cancer tumor called papillary craniopharyngioma by over 90% on average, a new study reports. By Bree Iskandar Brandon Bell/Getty Images Three reasons why Chuck Schumer's crusade against Logan Paul's energy drink will likely fizzle out Sen. Chuck Schumer wants the FDA to investigate social media star Logan Paul's increasingly popular Prime energy drink. By Nicholas Florko Listen: Wegovy in the brain, pivotal Alzheimer's data, & pulling Threads STAT's Megan Molteni joins us to explain the evolving science suggesting that products like Wegovy could be treatments for human desire. By Damian Garde and Meg Tirrell and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser